Not an actual patient
It can be hard when your very young child has eczema. They can’t always tell you when it’s bothering them and having it come back again and again, despite your best efforts, can be frustrating.
DUPIXENT is the only FDA-approved biologic for treating uncontrolled moderate-to-severe eczema in children ages 6 months to 5 years. It helps heal your child’s skin from within and helps you get ahead of their eczema symptoms.
DUPIXENT in combination with a topical corticosteroid was studied in a 16-week clinical trial with 162 patients ages 6 months to 5 years with moderate-to-severe eczema not adequately controlled with topical prescription treatments.*
Children ages 6 months to 5 years taking DUPIXENT plus a topical corticosteroid (TCS) saw clearer skin and less itch.
Your healthcare provider will tell you how much DUPIXENT to inject and how often.
*Children (6 months to 5 years of age) received DUPIXENT 200mg or 300mg every 4 weeks basedon weight, with no initial loading dose.
The safety results of DUPIXENT plus topical corticosteroids observed in children (6 months to 5 years) were consistent with what was seen in adults, adolescents, and children (6 to 11 years old) with atopic dermatitis. The most common side effects in clinical trial adult patients with atopic dermatitis include injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, cold sores in your mouth or on your lips, and high count of a certain white blood cell (eosinophilia).
View the possible side effects of DUPIXENT in patients with moderate-to-severe eczema (atopic dermatitis).
In a clinical trial for children ages 6 months to 5 years, clearer skin was seen. Use the slider to view before and after results of an actual 4-year-old patient after 16 weeks of treatment with DUPIXENT and a topical steroid in a phase 3 clinical trial. A clinical responder was defined as a patient achieving IGA 0 or 1 (clear or almost clear skin). Individual results may vary.
Expand the boxes below to see more detailed results from the clinical study with patients ages 6 months to 5 years.
Results at 16 weeks when DUPIXENT was taken with topical corticosteroids (TCS) compared to
patients ages 6 months to 5 years on topical corticosteroids only
28% saw clear or almost clear skin when DUPIXENT was used with TCS vs 4% on topical corticosteroids only
53% saw at least a 75% skin improvement when DUPIXENT was used with TCS vs 11% on topical corticosteroids only
25% saw at least a 90% skin improvement when DUPIXENT was used with TCS vs 3% on topical corticosteroids only
At 16 weeks, patients ages 6 months to 5 years experienced a significant reduction in itch while participating in a clinical trial.
48% had significant itch reduction when DUPIXENT was used with TCS vs 9% on topical corticosteroids only
Use this Healthgrades™ tool to easily find nearby
specialists with experience in treating children , teens,
and adults with uncontrolled moderate-to-severe
eczema (atopic dermatitis).
Our goal is for you to get the most out of your visit to your child’s doctor so you can better understand eczema and find the right treatment option for your family. Fill out our personalized discussion guide to help yourself have a productive conversation during your next visit.
Many parents find it helpful to use distraction techniques when giving injections to a young child. Here are a few methods you may find useful at injection time.
Infants (6-12 Months)
Toddlers (1-3 Years)
Preschoolers (3-5 Years)
Find more tips like these and other resources for parents with DUPIXENT MyWay.SIGN UP
We understand that you may have questions about DUPIXENT and how it is administered to young children. Don’t worry—we’re here to help.
Head to the How DUPIXENT Is Taken page to learn about the different methods of administration, recommended dosing, and to find more injection support resources.